| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.048 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |